Primary Prevention of Cardiovascular Disease Important in People With HIV

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of preventive management than in the general population.

Last year, an HHS panel released recommendations for the use of statin therapy as primary prevention of atherosclerotic cardiovascular disease (ASCVD) in people with HIV. Researchers are continuing to explore whether other agents, such as anti-inflammatory drugs, may reduce such risks, and how to manage the higher risk of heart failure in this population, which statins cannot address.

New Recommendations for Statins in People With HIV

New clinical guidelines published in May described in more depth the justification for the statin recommendations, the evidence behind them, and the remaining gaps in research.

Th